Concessão da patente
#16.1
20 (vinte) anos contados a partir de 16/11/2012, observadas as condições legais
04/12/2022
RPI 2675
Application data
Number
112015010756Type
Filing
Publication
PCT
US2012065386 The patent was granted on 04/12/2022 and is in force until 11/16/2032. Until then, no one may make, use or sell the invention in Brazil without the owner's authorisation.
Protection valid until:11/16/2032
Latest action published by the INPI: 04/12/2022. We update with every new RPI gazette, published weekly.
Applicants
UNITED BIOMEDICAL, INC.
US
Inventors
C. W. (pessoa física)
US
IPC Classification
Abstract
ABSTRACT Synthetic FMD peptide immunogens and compositions containing the same are disclosed. Methods for detecting, treating, and preventing an FMD infection in an animal using the synthetic FMD peptide immunogens are also disclosed. In a specific embodiment, a peptide-based emergency vaccine and formulations thereof against Foot and Mouth Disease is described. Various vaccine formulations contain a mixture of peptides derived from FMDV VP1 protein; each peptide containing a B cell FMDV neutralizing/receptor binding epitope sequence linked to an artificial Th epitope to enhance the immunogenicity of each peptide. Disclosed vaccine formulations containing viral immunogens can optionally be supplemented with a mixture of peptides representing the FMDV endogenous Th epitopes derived from FMDV proteins, homologues and functional analogues thereof. Such viral peptide compositions are prepared in an acceptable delivery system as vaccine formulations and can provide protection pigs and cattle from infection upon FMDV challenge with only single administration.
Publications in the Brazilian Industrial Property Gazette (RPI).
#16.1
20 (vinte) anos contados a partir de 16/11/2012, observadas as condições legais
04/12/2022
RPI 2675
#9.1
02/22/2022
RPI 2668
12/28/2021
RPI 2660
#8.6
Referente à 9ª anuidade.
09/08/2021
RPI 2644
#6.1
07/27/2021
RPI 2638
#6.21
08/20/2019
RPI 2537
NOTIFICAÇÃO DE DEVOLUÇÃO DO PEDIDO POR NÃO SE ENQUADRAR NO ART. 229-C DA LPI.
01/29/2019
RPI 2508
#7.4
De acordo com o artigo 229-C da Lei nº 10196/2001, que modificou a Lei nº 9279/96, a concessão da patente está condicionada à anuência prévia da ANVISA. Considerando a aprovação dos termos do Parecer nº 337/PGF/EA/2010, bem como a Portaria Interministerial Nº 1065 de 24/05/2012, encaminha-se o presente pedido para as providências cabíveis.
01/23/2018
RPI 2455
#1.3.1
Referente à RPI 2433 de 22/08/2017,quanto ao item (54).
01/16/2018
RPI 2454
#1.3
08/22/2017
RPI 2433
#1.1
05/26/2015
RPI 2316
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.